A global advocacy initiative
Always for those who depend on insulin. At least two weeks a year for everyone else. That's the standard cgm4all is fighting for — in Europe, and around the world.
Denmark · 2026
Denmark’s 2027 finance bill proposes DKK 200 million annually for 2027–2030, shared with women’s health and fertility. Sensor access for people with type 2 diabetes is part of the proposal; parliamentary approval is still needed.
Diabetesforeningen ↗ (opens in a new tab)The picture today
People with diabetes worldwide
An estimated 589 million adults live with diabetes globally today — including 32 million in the European Union. That number is projected to rise sharply by 2030.
A story
"Every type 2 patient should be equipped with a sensor for a period at the onset of illness."
— 2SENSE pilot study participant, Denmark · Diabetesforeningen (2024)
Our ask
CGM for all insulin-dependent types.
And at least two weeks of reimbursed CGM each year for everyone with non-insulin-dependent diabetes.
Latest milestone
Launching the cgm4all coalition — first partners onboarding across Europe, with global chapters forming next.
Follow the campaign
@cgm4all
Follow us on Instagram →Join the movement
Read the case for CGM, share it with your representatives, and follow along as we push for policy change worldwide.
